Financhill
Buy
61

CMPX Quote, Financials, Valuation and Earnings

Last price:
$5.18
Seasonality move :
-8.55%
Day range:
$5.19 - $5.45
52-week range:
$1.33 - $5.86
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.39x
Volume:
1.8M
Avg. volume:
1.9M
1-year change:
270.34%
Market cap:
$920.4M
Revenue:
$850K
EPS (TTM):
-$0.46

Earnings Data

Next earnings date for CMPX
Feb 26
2026
Most recent earnings per share
-$0.08
Beat by $0.05
(Nov 5/2025)
Consensus Estimate
-$0.13
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CMPX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -$1.1M -- -- -$0.10 --
02/26/2026 Q4 -- -- -- -$0.09 --
11/05/2025 Q3 -- -- -$0.08 -$0.13 $0.05
08/11/2025 Q2 -- -- -$0.14 -$0.12 -$0.03
05/15/2025 Q1 -- -- -$0.12 -$0.11 -$0.01
02/27/2025 Q4 -- -- -$0.11 -$0.09 -$0.01
11/12/2024 Q3 -- -- -$0.08 -$0.11 $0.03
08/12/2024 Q2 -- $850K -$0.10 -$0.10 --
05/13/2024 Q1 -- -- -$0.08 -$0.11 $0.03
03/21/2024 Q4 -- -- -$0.11 -$0.09 -$0.02
11/09/2023 Q3 -- -- -$0.08 -- --
08/03/2023 Q2 -- -- -$0.09 -- --
05/04/2023 Q1 -- -- -$0.06 -- --
03/15/2023 Q4 -- -- -$0.10 -- --
11/09/2022 Q3 -- -- -$0.12 -- --
08/01/2022 Q2 -- -- -$0.08 -- --
05/09/2022 Q1 -- -- -$0.07 -- --
03/21/2022 Q4 -- -- -$0.13 -- --
11/12/2021 Q3 -- -- -$0.10 -- --
08/16/2021 Q2 -- -- -$1.08 -- --
03/31/2021 Q1 -- -- -$0.14 -- --
12/31/2020 Q4 -- -- -$0.16 -- --
09/30/2020 Q3 -- -- -$0.18 -- --
06/30/2020 Q2 -- -- -$0.11 -- --
03/31/2020 Q1 -- -- -$0.12 -- --
12/31/2019 Q4 -- -- -$0.13 -- --
09/30/2019 Q3 -- -- -$0.16 -- --
06/30/2019 Q2 -- -- -$0.17 -- --
03/31/2019 Q1 -- -- -$0.21 -- --

Compass Therapeutics, Inc. Earnings Questions

  • How Much did Compass Therapeutics, Inc. Generate in Revenue Last Quarter?

    Compass Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Compass Therapeutics, Inc. Beat Earnings Last Quarter?

    Compass Therapeutics, Inc. announced earnings per share of -$0.08 which represents a beat of analyst forecast a -$0.13 per share.

  • Is Compass Therapeutics, Inc. Profitable?

    Compass Therapeutics, Inc. reported -$371K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Compass Therapeutics, Inc. EPS Next Year?

    Compass Therapeutics, Inc.'s earnings are forecast to decrease from -$0.36 per share to -$0.42 per share next year representing a decrease of -16.61%.

  • When is Compass Therapeutics, Inc.'s Earnings Date?

    Compass Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
55
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
45
CTEV alert for Jan 2

Claritev Corp. [CTEV] is down 20.7% over the past day.

Sell
47
ASTS alert for Jan 2

AST Spacemobile, Inc. [ASTS] is up 14.94% over the past day.

Buy
60
BIDU alert for Jan 3

Baidu, Inc. [BIDU] is up 15.01% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock